Sharon M Weber, MD, FACS

Professor

  • Chair, Division of Surgical Oncology
  • Medical Director of Surgical Oncology, UW Carbone Cancer Center
  • Endowed Professor, Tim and Mary Ann McKenzie Professorship in Surgical Oncology

webers@surgery.wisc.edu
(608) 262-2025

  • Administrative Assistant: (608) 262-2025

600 Highland Avenue
Clinical Science Center
Madison, Wisconsin 53792-7375

Education

  • MD, University of Wisconsin Medical School, Madison, WI
  • Residency in General Surgery, University of Wisconsin Hospital and Clinics, Madison, WI
  • Research Fellowship in Tumor Immunotherapy, University of Wisconsin Medical School, Madison, WI
  • Surgical Oncology Fellowship, Memorial Sloan-Kettering Cancer Center, New York, NY
  • Hepatobiliary Fellowship, Memorial Sloan-Kettering Cancer Center, New York, NY

Clinical Specialties

Dr. Weber is actively involved in minimally invasive approaches to cancer treatment, including both laparoscopic pancreas and liver surgery. She has been invited as a speaker/moderator at many national meetings, including the American College of Surgeons, the American Hepatopancreaticobiliary Association, Society of Surgical Oncology, and Society of University Surgeons.

Research Interests

Dr. Weber conducts translational research at the UW Carbone Cancer Center evaluating novel tumor selective agents which may be promising for imaging and/or treating tumors. She also conducts clinical research evaluating prognosticators of outcome in patients with liver, bile duct, and liver tumors. Dr. Weber’s research interests also include mixed methods evaluation of risk factors for readmission using a systems engineering approach with a focus on the transition of care and outcomes research evaluating preoperative predictors of postoperative complications.

Recent Publications

  • Incidence and Prognostic Implications of Lymphovascular Invasion in Node-Negative Pancreatic Neuroendocrine Tumors: Results From the US Neuroendocrine Study Group.
    Sahara K, Tsilimigras DI, Homma Y, Kawashima J, Maithel SK, Rocha F, Weber S, Fields R, Idrees K, Poultsides GA, Cho C, Endo I, Pawlik TM
    J Surg Oncol 2024 Oct 13;
    [PubMed ID: 39400348]

  • Preoperative Glycosylated Hemoglobin A1C Impacts Long-Term Outcomes Following Curative-Intent Resection of Nonfunctional Gastroenteropancreatic Neuroendocrine Tumors.
    Li MX, Lopez-Aguiar AG, Poultsides G, Rocha F, Weber S, Fields R, Idrees K, Cho C, Maithel SK, Zhang XF, Pawlik TM
    J Surg Oncol 2024 Oct 10;
    [PubMed ID: 39387595]

  • Understanding futility in pancreaticoduodenectomy: Insights from a national cohort.
    Marcinak CT, Ahmed KS, LoConte NK, Praska CE, Varley PR, Weber SM, Abbott DE, Ronnekleiv-Kelly SM, Kratz JD, Lubner SJ, Minter RM, Zafar SN
    J Surg Oncol 2024 Sep; 130(3): 462-475
    [PubMed ID: 39082628]

  • Beyond borders: insights from the Society of Surgery for the Alimentary Tract Junior Surgeon Travel Exchange Program.
    Szor DJ, Zafar SN, Weber S, Ribeiro U
    J Gastrointest Surg 2024 Jun; 28(6): 993-994
    [PubMed ID: 38579931]

  • Preoperative anemia: impact on short- and long-term outcomes following curative-intent resection of gastroenteropancreatic neuroendocrine tumors.
    Xiang JX, Nan YL, He J, Lopez-Aguiar AG, Poultsides G, Rocha F, Weber S, Fields R, Idrees K, Cho C, Maithel SK, Lv Y, Zhang XF, Pawlik TM
    J Gastrointest Surg 2024 Jun; 28(6): 852-859
    [PubMed ID: 38538480]

All Publications on PubMed